Microarrays help keep induced pluripotent stem cell lines in check, from start to finish.
The Scientist
Most Recent
Research purporting to cure patients with heart disease using induced pluripotent stem cells may be a fraud.
To cope with a growing shortage of hearts, livers, and lungs suitable for transplant, some scientists are genetically engineering pigs, while others are growing organs in the lab.
Japanese researchers are launching an iPS cell trial for an untreatable eye disease, challenging ongoing embryonic stem cell trials.
Researchers generate pluripotent stem cells from two endangered species in hopes of learning more about the near-extinct animals.
Cells derived from embryonic and induced pluripotent stem cells exhibit striking differences from the cells they’re supposed to represent.
Is DNA damage an inevitable consequence of epigenetic reprogramming?
Rudolf Jaenisch enjoys climbing mountains, rafting rapids, and unraveling the secrets of pluripotency—knowledge that could someday lead to personalized regenerative medicine.
Page 1 of 1
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
